Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KDM3B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | POM121 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C1orf109 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | USP24 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MZT1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZNF770 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | COQ10B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZSCAN5B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | LRRC37A2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FBXO45 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |